🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Softgel(s) Serving Size
40 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
33 {Calories}
Total Fat
3 g (2% DV)
Cholesterol
12 mg (1% DV)
Sodium
Total Carbohydrates
300 mg (1% DV)
Protein
900 mg (1% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 360mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 240mg UL 3000mg

Other Ingredients

Fish Oil concentrate Gelatin Glycerin Water

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement, take three (3) softgels daily, or as directed by a healthcare professional.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

OL products are free of most allergens such as corn, yeast, barley, wheat, soy, lactose, gluten, citrus, egg products as well as added flavorings, sugar sweeteners, salt, preservatives, salicylates, and artificial colors and coatings.

Additional Information

Researched Ingredients Naturopathic Division

3000 mg Per Serving

OL the world's finest supplements

Made in USA

When you buy OL, you are buying the best.

Confused on what to take? Check yourself at: WhatVitaminsAreRightForYou.com

STORE IN A COOL, DRY PLACE.

Product Details

UPC / SKU 7 10013 03071 9
DSLD Entry Date 2012-06-01
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 9738
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →